Diamel in the Treatment of Polycystic Ovary Syndrome
The purpose of this study is to assess the efficacy of Diamel administration in the treatment of Polycystic Ovary Syndrome. The duration of this double-blind placebo controlled phase 3 clinical trial will be 24 weeks.
Polycystic Ovary Syndrome
DIETARY_SUPPLEMENT: Diamel|DIETARY_SUPPLEMENT: Placebo
Normalization of blood concentrations of androgens at week 24, 24 weeks|Normalization of blood concentrations prolactin at week 24, 24 weeks|Normalization of blood concentrations of estrogens at week 24, 24 weeks|Normalization of blood concentrations of FSH at week 24, 24 weeks|Normalization of blood concentrations of LH at week 24, 24 weeks
Regularization of the menstrual cycle at week 24., 24 weeks|Reappearance of ovulatory cycles at week 24, 24 weeks|Normalization of blood concentrations of insulin at week 24, 24 weeks|Normalization of blood concentrations of cholesterol at week 24, 24 weeks|Normalization of blood concentrations of triglycerides at week 24, 24 weeks|Normalization of blood concentrations of glucose at week 24, 24 weeks|Improvement of clinical signs associated with polycystic ovary syndrome: acne, hirsutism, abdominal obesity, and blood pressure at week 24., 24 weeks
The purpose of this study is to assess the efficacy of Diamel administration in the treatment of Polycystic Ovary Syndrome. The duration of this double-blind placebo controlled phase 3 clinical trial will be 24 weeks.